CYBB and Hepatic fibrosis: Notably, this mechanism parallels research on liver fibrosis, where the inhibition of ROS levels and NOX2 expression in the liver was shown to reduce collagen production and suppress the activation of ERK and JNK signaling pathways, thereby halting the progression of liver fibrosis [59].